• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Teva Pharmaceutical Industries Ltd

+ Add to Watchlist

TEVA:US

56.5800 USD 0.6500 1.14%

As of 20:04:04 ET on 11/25/2014.

Snapshot for Teva Pharmaceutical Industries Ltd (TEVA)

Open: 57.0800 Day's Range: 56.4250 - 57.1200 Volume: 2,873,453
Previous Close: 57.2300 52wk Range: 38.9700 - 58.8700 1-Yr Rtn: +42.70%

Stock Chart for TEVA

No chart data available.
  • TEVA:US 56.5800
  • 1D
  • 1M
  • 1Y
57.2300
Interactive TEVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TEVA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 11.2151
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 5.0450
Est. PEG Ratio 5.3456
Market Cap (M USD) 48,319.32
Shares Outstanding (M) 854.00
30 Day Average Volume 4,637,479
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.24%
Cash Dividend (USD) 0.2696
Dividend Ex-Date 11/13/2014
5 Year Dividend Growth 19.00%
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TEVA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TEVA

Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.

Erez VigodmanPresident/CEOItzhak KrinskyChairman:Teva Japan & South Korea
Allan ObermanPresident & CEO:AmericasJudith VardiPresident & CEO:Emia & Asia Pacific
More Company Profile & Key Executives for TEVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil